5: Denis Kalyshkin, I2BF Global Ventures

7: Steve Pinto, Ctrl Robotics

Next episode of Venture Vitals is on! This time, we invited Steve Pinto, CEO of Ctrl Robotics, to share the company's evolution from hotel automation to a software platform enabling businesses to automate logistics processes with robots, and to discuss their expansion into healthcare-specific hardware solutions. What are the challenges of implementing service robots in hospitals, including elevator access issues and strategies for selling healthcare technology solutions across different regions, along with advice on effective sales approaches and business roadmap planning? And has Steve enjoyed being one of this year's Caelestini? What is Ctrl Robotics? Ctrl is robotic automation made simple. Ctrl allows businesses like hotels, hospitals and warehouses to automate manual labour with modern, autonomous service robots. These robots perform delivery, cleaning, and similar tasks to save the business time and money, whilst improving service. https://ctrlrobotics.com [https://ctrlrobotics.com]

6: Max Klimeš and Tobiáš Vybíral, HTG Medical

In this episode of Venture Vitals, we dive into the world of medtech innovation with Max Klimeš and Tobias Vybíral, the minds behind HTG Medical. Starting as a bold idea at a Prague hackathon, their startup has grown into a promising healthtech venture, developing Urogram—a smart, automated urine measurement device for Intensive Care Units (ICUs). Together with hosts Evgeny and Tomas, they discuss: ✅ The journey from hackathon to securing early seed financing ✅ How understanding healthcare professionals’ needs shaped their product ✅ The challenge of navigating investor relations in the medtech sector ✅ The future of digital health and how HTG Medical plans to scale HTG Medical is on a mission to modernize hospital workflows, reducing nurse workload and improving patient care. Their Urogram device seamlessly integrates into existing hospital systems, providing real-time urine output monitoring, a crucial metric for ICU patients. The episode also touches on the importance of authenticity in investor relations, lessons learned from piloting in hospitals, and the potential for HTG’s technology to expand beyond ICUs—even into space medicine. 🎧 Tune in to hear an inspiring startup story and gain valuable insights into the healthtech industry. 📍 Learn more about HTG Medical at htgmedical.com [http://htgmedical.com]. #VentureVitals #HealthTech #MedTech #Startups #DigitalHealth #ICU #MedicalInnovation #HackathonSuccess

5: Denis Kalyshkin, I2BF Global Ventures

Denis Kalyshkin is a  Principal at I2BF Global Ventures, a New York-based early-stage venture capital firm specializing in transforming traditionally overlooked industries, vertical SaaS, and digital healthcare. Denis is also the co-founder of Ask VC, a media platform for startup founders, and Space Ambition, a comprehensive resource hub for SpaceTech entrepreneurs, investors, and ecosystem builders. LinkedIn: https://www.linkedin.com/in/denis-kalyshkin-b634592a [https://www.linkedin.com/in/denis-kalyshkin-b634592a?trk=blended-typeahead] Ask VC: https://www.linkedin.com/company/ask-vc-global [https://www.linkedin.com/company/ask-vc-global?trk=blended-typeahead] Space Ambition: https://spaceambition.substack.com [https://spaceambition.substack.com/] Pre-Seed to succeed investment program: https://p2s.vc [https://p2s.vc/] Some useful links for founders Cold contacting VCs: https://blog.i2bf.com/cold-emails-vc [https://blog.i2bf.com/cold-emails-vc] Updates for investors: https://blog.i2bf.com/investor-updates [https://blog.i2bf.com/investor-updates] Vertical AI future: https://blog.i2bf.com/vertical-ai-future [https://blog.i2bf.com/vertical-ai-future]

4: Mike Zack, PGxAI

In their fourth epizode, Venture Vitals’ Tomas Studenik and Evgeny Shvarov invited a precision medicine startup CEO, Mike, to be their guest and respondent for over 45 minutes of all-about-building-a-global-med-tech-unicorn. Mike Zack, MD, PhD, MPH, is the Co-Founder and CEO of PGxAI (https://pgx.ai [https://pgx.ai/]), a key opinion leader (KOL) in pharmacogenomics with an H-index of 40 and >40K citations. Mike is a member of major pharmacogenomics consortiums, including CPIC and PGRN, and has published in top-tier journals such as Nature Pharmacogenomics Journal, The Lancet, and others. Mike is supported by his co-founder and investor Allan Gobbs, who has successfully exited nine companies, and Russ Altman, a Stanford professor, serial entrepreneur, and world-leading KOL in multi-omics. PGX.ai [http://PGX.ai] is a Caelestinus Health Tech Incubator alumnus.

3: Antxon Caballero, Heuristik

In the latest episode of Venture Vitals, Tomas Studenik and Evgeny Shvarov sit down with Antxon Caballero, CEO of Heuristik, to explore the complex landscape of doing business with hospitals in Spain, EU as well as U.S. From navigating identity verification issues to managing high-damage claims, Antxon shares valuable insights on mitigating risks in health tech. They also dive deep into opportunities for innovation in healthcare IT systems and the importance of incubation and acceleration programs for startups. Tune in for expert advice on scaling in digital health, securing investor interest, and the steps to becoming the next unicorn in the industry. Antxon Caballero - CEO, Heuristik Antxon is a serial entrepreneur with a successful exit. Antxon has international experience in sales and team management, he founded Heuristik after his grandfather almost died because of an identification error. What is Heuristik? The WHO says that you have 10% chances of being wrong identified, in Europe over 500M patients suffer identification errors every year with a market cost of over €200B. Clearly the current patient identification solutions are not working and that's why we created Heuristik, Heuristik is a software solution to identify and manage patients combining fingerprints and artificial intelligence. Using Heuristik healthcare entities can identify patients during the whole patient journey using their fingerprint and obtain real time statistics to avoid bottlenecks. See www.heuristik.tech [https://www.heuristik.tech]